Europe Self-Monitoring Blood Glucose Devices Market to Reach $6.5 Bn by 2024- Abbott, All Medicus, ARKRAY, Inc., Bayer Pharmaceuticals, Dexcom, Johnson & Johnson
Europe self-monitoring blood glucose (SMBG) devices market size was valued at USD 4.7 billion in 2017 and is expected to witness growth of more than 4.9% CAGR from 2018 to 2024. Rising prevalence of diabetes in Europe is the key factor that will drive Europe self-monitoring blood glucose devices market during the forecast period.
View full press release